HUP0103204A2 - Új, görcsoldó hatású 4-amino-1-aril-piridin-2-on-származékok, eljárás az előállításukra, alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények - Google Patents
Új, görcsoldó hatású 4-amino-1-aril-piridin-2-on-származékok, eljárás az előállításukra, alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0103204A2 HUP0103204A2 HU0103204A HUP0103204A HUP0103204A2 HU P0103204 A2 HUP0103204 A2 HU P0103204A2 HU 0103204 A HU0103204 A HU 0103204A HU P0103204 A HUP0103204 A HU P0103204A HU P0103204 A2 HUP0103204 A2 HU P0103204A2
- Authority
- HU
- Hungary
- Prior art keywords
- amino
- aryl
- new
- pyridine
- ones
- Prior art date
Links
- 230000002082 anti-convulsion Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- -1 trifluoromethyl- Chemical group 0.000 abstract 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
A tal lm ny új (1) ltal nos képletű 4-amino-1-aril-piridin-2-onszrmazékokra, elő llít sukra szolg ló elj r sra, valamintgyógyszerkénti, főleg kül"nb"ző epilepsziaform k kezelésére alkalmasgyógyszerkénti alkalmaz sukra vonatkozik. Az (1) ltal nos képletben nértéke 0, 1, 2, 3, 4 vagy 5, X jelentése hidrogénatom, C1-C4-alkil-,C1-C4-alkoxi-, trifluormetil-, trifluormetoxicsoport vagy halogénatomés A jelentése amino-, C1-C4-alkilamino-, C1-C4-dialkilamino-,morfolino-, piperidino- vagy pirrolidinocsoport. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19835918A DE19835918A1 (de) | 1998-08-07 | 1998-08-07 | Neue antikonvulsiv wirkende 4-Amino-1-aryl-pyridin-2-one und Verfahren zu deren Herstellung |
PCT/EP1999/005399 WO2000007988A1 (de) | 1998-08-07 | 1999-07-28 | Neue, antikonvulsiv wirkende 4-amino-1-aryl-pyridin-2-one und verfahren zu deren herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0103204A2 true HUP0103204A2 (hu) | 2002-04-29 |
HUP0103204A3 HUP0103204A3 (en) | 2002-06-28 |
Family
ID=7876889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0103204A HUP0103204A3 (en) | 1998-08-07 | 1999-07-28 | New 4-amino-1-aryl-pyridine-2-ones with anticonvulsive action and method for producing same, their use and pharmaceutical compositions containing them |
Country Status (21)
Country | Link |
---|---|
US (1) | US6071911A (hu) |
EP (1) | EP1102748A1 (hu) |
JP (1) | JP2002522420A (hu) |
KR (1) | KR20010074802A (hu) |
CN (1) | CN1322197A (hu) |
AR (1) | AR021186A1 (hu) |
AU (1) | AU5507499A (hu) |
BG (1) | BG105196A (hu) |
BR (1) | BR9912849A (hu) |
CA (1) | CA2279692C (hu) |
DE (1) | DE19835918A1 (hu) |
HU (1) | HUP0103204A3 (hu) |
IL (1) | IL141200A0 (hu) |
NO (1) | NO20010575L (hu) |
NZ (1) | NZ509914A (hu) |
PL (1) | PL346013A1 (hu) |
RU (1) | RU2001106634A (hu) |
SK (1) | SK2002001A3 (hu) |
TR (1) | TR200100370T2 (hu) |
WO (1) | WO2000007988A1 (hu) |
ZA (1) | ZA200100999B (hu) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL152848A0 (en) | 2000-06-12 | 2003-06-24 | Eisai Co Ltd | 1,2-dihydropyridine derivatives, pharmaceutical compositions containing the same and methods for the production thereof |
GB0129260D0 (en) | 2001-12-06 | 2002-01-23 | Eisai London Res Lab Ltd | Pharmaceutical compositions and their uses |
MY148809A (en) | 2004-07-06 | 2013-05-31 | Eisai R&D Man Co Ltd | Crystals of 1,2-dihydropyridine compound and their production process |
BR112021010953A2 (pt) | 2018-12-14 | 2021-08-24 | Eisai R&D Management Co., Ltd. | Formulações farmacêuticas de base aquosa de compostos de 1,2-di-hidropiridina |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51118768A (en) * | 1975-02-19 | 1976-10-18 | Shigeo Senda | Method for preparing 4-amino-2-pyridone derivatives |
DE3369315D1 (en) * | 1982-10-27 | 1987-02-26 | Degussa | Derivatives of 2-amino-3-acylamino-6-benzylamino pyridine with an anti-epileptic activity |
-
1998
- 1998-08-07 DE DE19835918A patent/DE19835918A1/de not_active Withdrawn
-
1999
- 1999-07-28 PL PL99346013A patent/PL346013A1/xx unknown
- 1999-07-28 RU RU2001106634/04A patent/RU2001106634A/ru unknown
- 1999-07-28 HU HU0103204A patent/HUP0103204A3/hu unknown
- 1999-07-28 CN CN99811849A patent/CN1322197A/zh active Pending
- 1999-07-28 TR TR2001/00370T patent/TR200100370T2/xx unknown
- 1999-07-28 AU AU55074/99A patent/AU5507499A/en not_active Abandoned
- 1999-07-28 BR BR9912849-7A patent/BR9912849A/pt not_active IP Right Cessation
- 1999-07-28 IL IL14120099A patent/IL141200A0/xx unknown
- 1999-07-28 SK SK200-2001A patent/SK2002001A3/sk unknown
- 1999-07-28 WO PCT/EP1999/005399 patent/WO2000007988A1/de not_active Application Discontinuation
- 1999-07-28 NZ NZ509914A patent/NZ509914A/xx unknown
- 1999-07-28 KR KR1020017001574A patent/KR20010074802A/ko not_active Application Discontinuation
- 1999-07-28 JP JP2000563622A patent/JP2002522420A/ja active Pending
- 1999-07-28 EP EP99941472A patent/EP1102748A1/de not_active Withdrawn
- 1999-08-05 CA CA002279692A patent/CA2279692C/en not_active Expired - Fee Related
- 1999-08-06 AR ARP990103952A patent/AR021186A1/es not_active Application Discontinuation
- 1999-08-06 US US09/370,640 patent/US6071911A/en not_active Expired - Fee Related
-
2001
- 2001-01-30 BG BG105196A patent/BG105196A/xx unknown
- 2001-02-02 NO NO20010575A patent/NO20010575L/no unknown
- 2001-02-06 ZA ZA200100999A patent/ZA200100999B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR021186A1 (es) | 2002-07-03 |
RU2001106634A (ru) | 2004-02-27 |
ZA200100999B (en) | 2001-12-14 |
AU5507499A (en) | 2000-02-28 |
PL346013A1 (en) | 2002-01-14 |
BG105196A (en) | 2001-12-29 |
NO20010575D0 (no) | 2001-02-02 |
NZ509914A (en) | 2002-11-26 |
HUP0103204A3 (en) | 2002-06-28 |
EP1102748A1 (de) | 2001-05-30 |
IL141200A0 (en) | 2002-02-10 |
CA2279692A1 (en) | 2000-02-07 |
TR200100370T2 (tr) | 2001-08-21 |
SK2002001A3 (en) | 2002-01-07 |
NO20010575L (no) | 2001-04-04 |
CA2279692C (en) | 2003-10-07 |
JP2002522420A (ja) | 2002-07-23 |
DE19835918A1 (de) | 2000-02-10 |
WO2000007988A1 (de) | 2000-02-17 |
CN1322197A (zh) | 2001-11-14 |
KR20010074802A (ko) | 2001-08-09 |
US6071911A (en) | 2000-06-06 |
BR9912849A (pt) | 2001-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT36784A (en) | Process for producing spasmolytic sulfanate derivatives and pharmaceutical compositions containing them as active agents | |
ATE212223T1 (de) | Verwendung von sertraline zur herstellung eines arzneimittels zur behandlung von obsessiv- kompulsiven erkrankungen | |
HUP0101192A2 (hu) | Cikloalkénszármazékok, előállításuk és alkalmazásuk | |
CA2333965A1 (en) | Method of enhancing lysosomal .alpha.-galactosidase a | |
AU4724599A (en) | Treatment of hyperproliferative disorders | |
MX9802130A (es) | Agonistas adrenergicos beta3 selectivos. | |
DE60133716D1 (de) | Verwendungen eines getränks enthaltend ein polyphosphat zur behandlung von zahnerosionen | |
RU94044453A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования себореи и угрей | |
ES8802014A1 (es) | Un procedimiento para la preparacion de derivados de ariletanolamina. | |
DE69506686D1 (de) | Verwendung von bis (amidinobenzidazolen) zur herstellung eines medikamentes für die hemmung der retroviral integrase | |
ATE314068T1 (de) | Behandlung von seborrhoischer dermatitis | |
RU94046141A (ru) | Замещенные производные /арилалкоксибензил/ аминопропанамида, способы их получения, фармацевтическая композиция | |
KR910007867A (ko) | 페네타놀아민 화합물 | |
HUP0103204A2 (hu) | Új, görcsoldó hatású 4-amino-1-aril-piridin-2-on-származékok, eljárás az előállításukra, alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények | |
RU94045271A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера | |
DE69227583T2 (de) | Arylmorpholine, herstellung und verwendung | |
HUP0004336A2 (hu) | Készítmény alkoholistákban fellépő megvonási tünetek és alkohol iránti ellenállhatatlan szükségérzet elnyomására és az alkohol túlzott mértékű fogyasztásának megelőzésére egészséges alanyokban | |
PL320342A1 (en) | Thrombin inhibitor containing infusion solution, stable during storage | |
KR940013503A (ko) | 동맥경화증의 예방 또는 치료용 약제학적 조성물 | |
HU9204171D0 (en) | Method for producing aralkyl esters of 4,5-dihydroxi-9,10-dihydro-9,10-dioxo-2-anthracene-carboxylic acid as well as medical preparatives containing them | |
HUT45250A (en) | Process for producing 5-substituted octahydro-indolysin derivatives and pharmaceutical compositions containing them as active components | |
JPS643185A (en) | Active compound, its production and pharmaceutical composition containing same | |
WO1995000154B1 (en) | Antidepressant agents with a rapid onset of action | |
UA34451C2 (uk) | 2,3,4,5-тетрагідро-1н-3-бензазепіни, що використовуються для лікування захворювань центральної нервової системи, спосіб їх одержання, фармацевтична композиція та спосіб лікування захворювань центральної нервової системи | |
RU94044455A (ru) | Средство для усиления функции макрофага и лечения человека с ослабленным иммунитетом |